-
- Posts: 108
- Joined: Fri Sep 03, 2004 3:42 pm
We have been requested to do method verifications on Inactive Pharmaceutical ingredients (IPI's) e.g Startch maize, Povidone, mag stearate and ethanol. The methods for these IPI's are based on the Ph. Eur and USP Pharmacopoeia.
Do you think it is necessary to do method verification on IPI's? Could we not do comparative testing i.e. compare our results to the supplier's results. Surely, this should be sufficient to show that we are able to execute the Pharmacopoeial methods. Our current practice is to do method verification on all Active Pharmaceutical Ingredients (API's). I think doing method verification i.e. specificity, precision etc. is "overkill" for IPI's.
Any comments/suggestions would be greatly appreciated.
Regards
Mike